(SFSN) SFS - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0239229302
SFSN: Fasteners, Components, Assemblies, Tools, Automation Systems
SFS Group AG (SW:SFSN) is a Swiss-based industrial powerhouse that engineers precision components and advanced fastening systems, serving a multitude of global industries. With a rich history dating back to 1928, the company has carved out a niche in high-precision manufacturing, operating across three core segments: Engineered Components, Fastening Systems, and Distribution & Logistics.
The Engineered Components division is the heartbeat of SFS, specializing in producing intricate parts and assemblies that are critical to their customers products. This segment serves industries like aerospace, automotive, and medical devices, where precision and reliability are paramount. The Fastening Systems division is another cornerstone, offering a wide array of fasteners, hinges, and other connection technologies that are essential for modern manufacturing.
The Distribution & Logistics segment rounds out their offerings, providing procurement solutions and distributing a vast range of industrial supplies. This not only diversifies their revenue streams but also positions them as a one-stop-shop for manufacturers looking to streamline their supply chains.
Under the SFS umbrella, youll find a portfolio of trusted brands such as UNISTEEL, Tegra Medical, and Hoffmann, each bringing their own expertise to the table. These brands collectively serve industries spanning from electronics and construction to medical technology and aerospace. Their product range is vast, encompassing everything from airbag systems and automation components to furniture fittings and life-saving fall protection equipment.
For investors, SFS Groups diversification across industries and geographies is a significant strength. Their exposure to high-growth areas like medical devices and automation positions them well for long-term growth. The companys commitment to R&D and its strong balance sheet further enhance its appeal. With a market cap of 4,495.29M CHF and a forward P/E of 11.79, SFS presents an intriguing opportunity for those seeking exposure to industrial innovation with a stable Swiss foundation.
Additional Sources for SFSN Stock
SFSN Stock Overview
| Market Cap in USD | 4,784m |
| Sector | Industrials |
| Industry | Tools & Accessories |
| GiC Sub-Industry | Industrial Machinery & Supplies & Components |
| IPO / Inception |
SFSN Stock Ratings
| Growth Rating | 21.0 |
| Fundamental | 72.3 |
| Dividend Rating | 10.5 |
| Rel. Strength | -9.37 |
| Analysts | - |
| Fair Price Momentum | 99.19 CHF |
| Fair Price DCF | 131.08 CHF |
SFSN Dividends
| Dividend Yield 12m | 1.10% |
| Yield on Cost 5y | 1.80% |
| Annual Growth 5y | -7.03% |
| Payout Consistency | 92.9% |
SFSN Growth Ratios
| Growth Correlation 3m | -33.6% |
| Growth Correlation 12m | -27.1% |
| Growth Correlation 5y | 33.6% |
| CAGR 5y | 8.62% |
| CAGR/Max DD 5y | 0.22 |
| Sharpe Ratio 12m | 1.56 |
| Alpha | -10.57 |
| Beta | 0.617 |
| Volatility | 30.60% |
| Current Volume | 30k |
| Average Volume 20d | 35.1k |
As of April 24, 2025, the stock is trading at CHF 105.00 with a total of 29,998 shares traded.
Over the past week, the price has changed by +1.94%, over one month by -10.10%, over three months by -13.79% and over the past year by -5.69%.
Yes, based on ValueRay Fundamental Analyses, SFS (SW:SFSN) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 72.25 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SFSN as of April 2025 is 99.19. This means that SFSN is currently overvalued and has a potential downside of -5.53%.
SFS has no consensus analysts rating.
According to ValueRays Forecast Model, SFSN SFS will be worth about 108.3 in April 2026. The stock is currently trading at 105.00. This means that the stock has a potential upside of +3.11%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 136.5 | 30% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 108.3 | 3.1% |